MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites

    M. Bruno, M. Matsunaga, E. Krening, J. Chen, G. Ross (Honolulu, USA)

    Objective: To determine if the proportion of hospitalized patients with Parkinson’s Disease (PD) in Hawaii differs among Native Hawaiians/Pacific Islanders (NHPI), American Asians (AA), and…
  • 2023 International Congress

    Accelerometric Classification of Resting and Postural Tremor in Essential Tremor and Parkinson’s Disease

    C. Hennen, T. Berger, GA. Brandt, JN. Strelow, H. Jergas, JC. Baldermann, MT. Barbe, JN. Petry-Schmelzer, TA. Dembek (Cologne, Germany)

    Objective: To investigate the predictive value of different accelerometry metrics for clinical ratings of Essential Tremor (ET) and tremor in Parkinson’s Disease (PD). Background: To…
  • 2023 International Congress

    Cerebellar ataxia in Hypomyelinating Leukodystrophies: A case series

    J. Ganguly, J. Sinha, P. Basu, M. Tiwari, H. Kumar (Kolkata, India)

    Objective: We present a case series of cerebellar ataxia due to hypomyelinating leukodystrophies (HLDs). Background: HLDs are a group of disorders arising from primary deficit…
  • 2023 International Congress

    Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

    D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)

    Objective: To determine the pharmacokinetic (PK) profile of L-3,4-dihydroxyphenylalanine (L-DOPA) in the common marmoset (Callithrix jacchus). Background: The common marmoset has been used to model…
  • 2023 International Congress

    Asymmetry of striatal dopaminergic function in essential tremor is associated with kinetic tremor asymmetry

    A. Kuusela, E. Honkanen, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, K-M. Murtomäki, T. Mertsalmi, T. Noponen, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate possible dopaminergic pathophysiology of essential tremor (ET) by focusing on tremor asymmetry. Background: Essential tremor (ET) is considered a non-dopaminergic movement disorder.…
  • 2023 International Congress

    Real-World Utilization of Istradefylline Among Patients with Parkinson’s Disease

    M. Rezak, J. Qian, Y. Zhao, A. Silverstein, J. Chamber, J. Swindle, N. Kronfeld, P. Lewitt (Hoffman estates, USA)

    Objective: This study examined real-world utilization of istradefylline and other PD-related medications before and after istradefylline initiation. Background: Istradefylline is indicated as adjunctive therapy to…
  • 2023 International Congress

    Anxiety in Parkinson’s disease is associated with changes in brain structural connectivity

    G. Carey, R. Viard, R. Lopes, G. Kuchcinski, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: The aim of this study was to identify White Matter (WM) changes by comparing Parkinson's disease (PD) patients with and without anxiety, using diffusion-tensor…
  • 2023 International Congress

    Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease

    M. Ruitenberg, E. Whooley, H. Macdonald, V. Koppelmans (Leiden, Netherlands)

    Objective: To assess the interplay of polygenic dopamine risk scores and psychiatric symptoms in the development of impulse control disorders (ICDs) in de novo patients…
  • 2023 International Congress

    Quantitative analysis of speech diadochokinetic rate in hereditary spastic paraplegia SPG3A

    V. Agrimaki, S. Siriopoulou, E. Zamba Papanicolaou, K. Christodoulou, K. Konstantopoulos (Kalamata, Greece)

    Objective: To analyze the dysarthria and speech diadochokinetic rate in a patient with hereditary spastic paraplegia (SPG3A). Background: Hereditary spastic paraplegias (HSP) are about 80…
  • 2023 International Congress

    Non-motor symptoms of Parkinson’s disease: an analysis of gender and age-related differences in a large online cohort

    D. Teixeira-Dos-Santos, G. Pereira, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: This study analyzed non-motor symptoms in newly diagnosed Parkinson’s disease (PD) patients and controls in a large online cohort, comparing four groups based on…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley